000 | 01957 a2200517 4500 | ||
---|---|---|---|
005 | 20250514204904.0 | ||
264 | 0 | _c20050329 | |
008 | 200503s 0 0 eng d | ||
022 | _a0022-3573 | ||
024 | 7 |
_a10.1211/0022357044481 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKonishi, Hiroki | |
245 | 0 | 0 |
_aDecrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats. _h[electronic resource] |
260 |
_bThe Journal of pharmacy and pharmacology _cOct 2004 |
||
300 |
_a1259-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xbiosynthesis |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xbiosynthesis |
650 | 0 | 4 |
_aBile _xdrug effects |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 | _aCytochrome P-450 CYP3A |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
650 | 0 | 4 |
_aIntestine, Small _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethylprednisolone Hemisuccinate _xadministration & dosage |
650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xbiosynthesis |
650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
650 | 0 | 4 | _aPulse Therapy, Drug |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
700 | 1 | _aSumi, Masaki | |
700 | 1 | _aShibata, Nobuhito | |
700 | 1 | _aTakada, Kanji | |
700 | 1 | _aMinouchi, Tokuzo | |
700 | 1 | _aYamaji, Akira | |
773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 56 _gno. 10 _gp. 1259-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1211/0022357044481 _zAvailable from publisher's website |
999 |
_c15173383 _d15173383 |